IRWD
Ironwood Pharmaceuticals Inc
$4.00
+0.02 (+0.50%)
At close · Jul 15
Market Cap
$637.05M
Shares
164,613,406
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-18 | 2026-06-16 | |
| 8-K | 2026-06-15 | — | |
| 8-K/A | 2026-05-21 | 2026-05-08 | |
| 8-K | 2026-05-13 | 2026-05-08 | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-28 | 2026-06-16 | |
| 8-K | 2026-03-11 | 2026-03-10 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-25 | — | |
| 8-K | 2026-01-02 | — | |
| 8-K | 2025-12-23 | 2025-12-18 | |
| 8-K | 2025-11-26 | 2025-11-25 | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-10-10 | 2025-10-07 | |
| 8-K | 2025-09-03 | 2025-08-29 | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-07-10 | 2025-07-03 | |
| 8-K | 2025-06-12 | 2025-06-10 | |
| 8-K | 2025-06-03 | 2025-05-28 | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| DEF 14A | 2025-04-28 | 2025-06-10 | |
| 8-K | 2025-04-25 | — | |
| 8-K | 2025-04-14 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-03-27 | 2025-03-21 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-29 | 2025-01-17 | |
| 8-K | 2024-12-05 | 2024-12-02 | |
| 8-K | 2024-11-12 | 2024-11-06 | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-09-30 | 2024-09-27 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-06-21 | — | |
| 8-K | 2024-06-20 | — | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| DEF 14A | 2024-04-25 | 2024-06-18 | |
| 10-K | 2024-02-16 | 2023-12-31 | |
| 8-K | 2024-02-15 | — | |
| 8-K | 2024-01-08 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K/A | 2023-09-11 | 2023-06-29 |
Showing 1–50 of 107 filings
Key facts
CIK
1446847
CUSIP
46333X108
13F (30d)
12 filings
12 filers
Visit website
Investor relations